The Court of Appeal of Quebec has rendered a judgment on the issue of new guidelines for the PMPRB – impact, consequences, and implications of this important decision.

The Court of Appeal of Quebec has rendered a judgment on the issue of new guidelines for the PMPRB – impact, consequences, and implications of this important decision.

This judgement, along with several others, calls into question the PMPRB’s approach to controlling prices.

The lawyers from Fasken Martineau DuMoulin LLP who worked directly on this issue will explain the particulars of this significant Court of Appeal decision and discuss the various impacts on our industry, such as strategies relating to patents and those involving the setting of prices.

A question period will follow.

*The presentation and question period will be bilingual

Our guests: 

Julie Desrosiers, Partner, Intellectual Property lawyer

Julie’s practice is currently focused almost exclusively on patent litigation. A seasoned litigator, she has been involved in several important patent infringement cases in the pharmaceutical sector. She has also acted in major copyright disputes resulting in precedent-setting decisions.

Mathieu Gagné, Partner

Mathieu specializes in pharmaceutical regulations and is the author of "Drug and Health Products Law in Canada". He has counselled various pharmaceutical companies on the standards governing the life cycle of drugs, from their inception to their consumption.

 

Dara Jospe, Associate, Lawyer

Dara Jospé practises law in the area of life sciences, health and food regulation. She advises manufacturers on all stages of the lifecycle of a pharmaceutical product, from conception until it reaches the consumer.

 

 

Join us! 

FREE FOR MEMBERS, $25 FOR NON-MEMBERS

Is my organization a member?
Click here to find out